Immunize.org has been refreshed! Take a tour.
  • Pneumococcal
  • Recommendations for Children

Which children are recommended to receive pneumococcal polysaccharide vaccine (PPSV23)?

All children should receive routine vaccination with PCV13 as age-appropriate. A child age 2 through 18 years should receive PPSV23 at least 8 weeks following the last recommended dose of PCV13 if they have any of the following conditions:

  1. alcoholism
  2. chronic liver disease, including cirrhosis
  3. chronic heart disease (e.g., congestive heart failure, cardiomyopathies), excluding hypertension
  4. chronic lung disease (including COPD and emphysema)
  5. diabetes mellitus
  6. candidate for or recipient of cochlear implant
  7. cerebrospinal fluid (CSF) leak
  8. functional or anatomic asplenia (e.g., splenectomy or congenital asplenia)
  9. sickle cell disease and other hemoglobinopathies
  10. congenital or acquired immunodeficiencies (e.g., B- (humoral) or T-lymphocyte deficiency, complement deficiencies (particularly C1, C2, C3, and C4), and phagocytic disorders (excluding chronic granulomatous disease)
  11. generalized malignancy
  12. HIV infection
  13. Hodgkin’s disease, leukemia, lymphoma, and multiple myeloma
  14. immunosuppression due to treatment with medication, including long-term systemic corticosteroids, and radiation therapy
  15. solid organ transplantation; for bone marrow transplantation, see www.cdc.gov/vaccines/hcp/acip-recs/general-recs/immunocompetence.html
  16. chronic renal failure or nephrotic syndrome
Last reviewed: July 26, 2022

This page was updated on .